Skip to main content
  • ASM
    • Antimicrobial Agents and Chemotherapy
    • Applied and Environmental Microbiology
    • Clinical Microbiology Reviews
    • Clinical and Vaccine Immunology
    • EcoSal Plus
    • Eukaryotic Cell
    • Infection and Immunity
    • Journal of Bacteriology
    • Journal of Clinical Microbiology
    • Journal of Microbiology & Biology Education
    • Journal of Virology
    • mBio
    • Microbiology and Molecular Biology Reviews
    • Microbiology Resource Announcements
    • Microbiology Spectrum
    • Molecular and Cellular Biology
    • mSphere
    • mSystems
  • Log in
  • My alerts
  • My Cart

Main menu

  • Home
  • Articles
    • Current Issue
    • Accepted Manuscripts
    • COVID-19 Special Collection
    • Archive
    • Minireviews
  • For Authors
    • Submit a Manuscript
    • Scope
    • Editorial Policy
    • Submission, Review, & Publication Processes
    • Organization and Format
    • Errata, Author Corrections, Retractions
    • Illustrations and Tables
    • Nomenclature
    • Abbreviations and Conventions
    • Publication Fees
    • Ethics Resources and Policies
  • About the Journal
    • About AAC
    • Editor in Chief
    • Editorial Board
    • For Reviewers
    • For the Media
    • For Librarians
    • For Advertisers
    • Alerts
    • AAC Podcast
    • RSS
    • FAQ
  • Subscribe
    • Members
    • Institutions
  • ASM
    • Antimicrobial Agents and Chemotherapy
    • Applied and Environmental Microbiology
    • Clinical Microbiology Reviews
    • Clinical and Vaccine Immunology
    • EcoSal Plus
    • Eukaryotic Cell
    • Infection and Immunity
    • Journal of Bacteriology
    • Journal of Clinical Microbiology
    • Journal of Microbiology & Biology Education
    • Journal of Virology
    • mBio
    • Microbiology and Molecular Biology Reviews
    • Microbiology Resource Announcements
    • Microbiology Spectrum
    • Molecular and Cellular Biology
    • mSphere
    • mSystems

User menu

  • Log in
  • My alerts
  • My Cart

Search

  • Advanced search
Antimicrobial Agents and Chemotherapy
publisher-logosite-logo

Advanced Search

  • Home
  • Articles
    • Current Issue
    • Accepted Manuscripts
    • COVID-19 Special Collection
    • Archive
    • Minireviews
  • For Authors
    • Submit a Manuscript
    • Scope
    • Editorial Policy
    • Submission, Review, & Publication Processes
    • Organization and Format
    • Errata, Author Corrections, Retractions
    • Illustrations and Tables
    • Nomenclature
    • Abbreviations and Conventions
    • Publication Fees
    • Ethics Resources and Policies
  • About the Journal
    • About AAC
    • Editor in Chief
    • Editorial Board
    • For Reviewers
    • For the Media
    • For Librarians
    • For Advertisers
    • Alerts
    • AAC Podcast
    • RSS
    • FAQ
  • Subscribe
    • Members
    • Institutions
Mechanisms of Resistance

Susceptibilities of Oral and Nasal Isolates ofStreptococcus mitis and Streptococcus oralis to Macrolides and PCR Detection of Resistance Genes

Tsuneko Ono, Sumiko Shiota, Katsuhiko Hirota, Ken Nemoto, Tomofusa Tsuchiya, Yoichiro Miyake
Tsuneko Ono
Department of Microbiology, Tokushima University School of Dentistry, Tokushima 770-8504, and
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Sumiko Shiota
Department of Microbiology, Faculty of Pharmaceutical Sciences, Okayama University, Okayama 700-8530, Japan
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Katsuhiko Hirota
Department of Microbiology, Tokushima University School of Dentistry, Tokushima 770-8504, and
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Ken Nemoto
Department of Microbiology, Tokushima University School of Dentistry, Tokushima 770-8504, and
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Tomofusa Tsuchiya
Department of Microbiology, Faculty of Pharmaceutical Sciences, Okayama University, Okayama 700-8530, Japan
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Yoichiro Miyake
Department of Microbiology, Tokushima University School of Dentistry, Tokushima 770-8504, and
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
DOI: 10.1128/AAC.44.4.1078-1080.2000
  • Article
  • Figures & Data
  • Info & Metrics
  • PDF
Loading

ABSTRACT

The susceptibility of viridans group streptococci to macrolides was determined. Thirteen isolates (17%) were resistant to erythromycin. Five strains carried an erm gene that was highly homologous to that in Tn917. Four strains had mefE genes that coded erythromycin efflux ability.

Viridans group streptococci, commensal bacteria in the human oral and nasal cavities, are associated with systemic diseases, including infective endocarditis, bacteremia, and pneumonia (2, 5, 6, 10, 12). Macrolide resistance has spread in staphylococci, enterococci, and streptococci (7-9, 11), but little is known about the distribution of the resistance among oral streptococci (12, 19). In this work, clinical isolates of oral and nasal Streptococcus mitis andStreptococcus oralis have been tested for susceptibility to macrolides, and resistance genes have been characterized.

Eighty-four streptococcal isolates from patients who visited Tokushima University Hospital between June and December 1995 were studied. These strains were isolated from periodontal pockets, larynx, pharynx, maxillary sinus, and nasal secretion and identified as S. oralis (54 strains), S. mitis (29 strains),Streptococcus sanguis (1 strain), and Streptococcus salivarius (1 strain) by biochemical tests, including the API-20 Strep system (bioMérieux, La Balme des Grottes, France).

The following antibiotics were used: leucomycin and midecamycin (Meiji Pharmaceutical Co., Ltd., Tokyo, Japan), erythromycin and rokitamycin (Asahi Kasei Co., Ltd., Tokyo, Japan), clarithromycin (Dynabott), azithromycin (Pfizer Pharmaceuticals), and roxithromycin (Hoechst-Marion-Roussel).

MICs were determined by a broth microdilution method in anaerobic MIC broth (Difco, Detroit, Mich.). Microtiter plates were incubated at 37°C for 24 h in 5% CO2.

Induction experiments for macrolide resistance were performed by preculture with a sub-MIC of erythromycin. Crude DNA of streptococci was prepared as previously described (13). PCR primers forerm and mefE were designed from published sequences (1) to provide specific PCR products of 530 and 1,218 bp, respectively. The erm primers were 5′-GAAATIGGIIIIGGIAAAGGICA-3′ and 5′-AAYTGRTTYTTIGTRAA-3′, and the mefE primers were 5′-ATGGAAAAATACAACAATTGGAAACGA-3′ and 5′-TTATTTTAAATCTAATTTTCTAACCTC-3′.

Macrolide susceptibility is shown in Table1. The erythromycin MICs at which 90% of the isolates tested are inhibited (MIC90s) for S. oralis and S. mitis were 8 and 32 μg/ml, respectively. MIC ranges of clarithromycin, azithromycin, and roxithromycin were similar to those of erythromycin. The MIC range of rokitamycin for S. oralis and S. mitis was narrow, with MIC90s of 0.5 and 1 μg/ml, respectively. Among 13 erythromycin-resistant strains (MIC, ≥8 μg/ml), 6 strains were highly resistant to erythromycin; the MICs for them were ≥512 μg/ml (Table 2). All of the strains except O14 were also highly resistant to clarithromycin, azithromycin, and roxithromycin, but intermediately resistant to rokitamycin (MIC, ≥0.5 to ≤2 μg/ml). Strain O14 was intermediately resistant to azithromycin and roxithromycin (MICs, ≥0.5 to ≤2 μg/ml) and sensitive to rokitamycin (MIC, ≤0.25 μg/ml). Seven strains were intermediately resistant to 14- and 15-member macrolides.

View this table:
  • View inline
  • View popup
Table 1.

In vitro activity of macrolide antibiotics for S. oralis and S. mitis

View this table:
  • View inline
  • View popup
Table 2.

MIC of macrolides in the presence and absence of inducera for erythromycin-resistant strains

As shown in Table 2, all erythromycin-resistant strains were more sensitive to rokitamycin than other macrolides. To determine whether resistance could be induced, MICs of 16-member macrolides for cells grown in medium with or without a sub-MIC of erythromycin were examined. Highly resistant strains SO12, SO13, O14, E2, and E21 were induced to develop resistance to rokitamycin, midecamycin, and leucomycin. Strain E3 was highly resistant to midecamycin and leucomycin, even when cultured without erythromycin, and rokitamycin resistance was not induced. The intermediately resistant strains, O24, E17, E11, E27, and E30, did not develop resistance to 16-member macrolides after erythromycin induction.

To clarify the mechanisms of resistance, PCR amplification of macrolide-resistant genes was performed. PCR primers for theerm (23S rRNA methylase) gene were designed based on the sequence of corresponding genes from other organisms. The highly resistant strains gave a distinct band of the expected 530-bp size from position 103 to position 633 of the erm gene. PCR products from these strains and S. salivarius E37 were sequenced (Fig. 1). Sequences from strains E2, E21, and E30 were identical to those of the gene encoding the rRNA methylase on transposon Tn917 (4). Those from other strains had ∼98% homology to Tn917. The nucleotide changes in strains SO12, SO13, and E37 resulted in six, four, and two amino acid alterations, respectively, but did not affect the reading frame. Primer sets for the mefE gene were designed based on the sequence of that gene in S. pneumoniae (GenBank U83667). The intermediately resistant strains O24, E17, and E3 and highly resistant strain O14 gave the expected band (approximately 1,200 bp) for themefE gene encoding the macrolide efflux pump (18). The sequences of DNA obtained from PCR amplification for mefE in strains O24, E3, and E17 were analyzed. These sequences were identical to those at positions 30 to 1190 of the corresponding mefE gene. Less erythromycin accumulated inmefE-positive strain E17 than in mefE-negative strain E1 15 min after the addition of [N-methyl-14C]erythromycin (data not shown). Accumulation of erythromycin in the mefE-positive strain was restored by addition of proton conductors, suggesting that a macrolide efflux system exists in strain E17. For genes encoding macrolide-inactivating enzyme, ereA, ereB, andmphE and macrolide efflux genes msr andmefA (17), PCR amplification was performed with DNA from macrolide-resistant strains; however, no PCR products have been detected.

Fig. 1.
  • Open in new tab
  • Download powerpoint
Fig. 1.

Nucleotide sequences of PCR products obtained with oral streptococci by using an erm primer set. The sequences in strains E2, E21, and E30 were identical to that from the site of theE. faecalis ermB gene. In strains E37, SO12, and SO13, only the base changes are shown (highlighted by asterisks).

Although erm genes encoding rRNA methylase are present in various organisms, such as Escherichia coli, Bacillus subtilis, and Staphylococcus aureus, and macrolide resistance is widespread in bacteria associated with humans (4, 15, 17), the potential reservoir for erm genes is unknown. It has been reported that the genes lie on various transposable elements or conjugal plasmids (4, 11, 14). In the present study, we showed that the nucleotide sequences of PCR products obtained with erm primers from some strains were identical to the rRNA methylase gene in Enterococcus faecalis transposon Tn917, while those from S. oralis SO12 and S. mitis SO13 were highly homologous with the ermB gene from conjugal plasmid pIP501 ofStreptococcus agalactiae (3, 4). In the upstream region, the sequence homologous to LR, an internal sequence of Tn917 has been found (16) (data not shown).S. oralis and S. mitis are major species in the oral and nasal normal flora. The results of this study suggest the transmission of macrolide-resistant genes between oral streptococci and other more virulent streptococci.

ACKNOWLEDGMENTS

We thank Kurumi Sugawara, Etsuko Lee, Noriko Hayashi, and Fumiko Aikawa for excellent technical assistance.

This work was supported by a grant-in-aid for Scientific Research (no. 10671703) to T.O. from the Ministry of Education, Science, Sports and Culture of Japan.

FOOTNOTES

    • Received 2 June 1999.
    • Returned for modification 2 September 1999.
    • Accepted 12 January 2000.
  • Copyright © 2000 American Society for Microbiology

REFERENCES

  1. 1.↵
    1. Arthur M.,
    2. Molinas C.,
    3. Mabilat C.,
    4. Courvalin P.
    Detection of erythromycin resistance by the polymerase chain reaction using primers in conserved regions of erm rRNA methylase genes. Antimicrob. Agents Chemother. 34 1990 2024 2026
    OpenUrlAbstract/FREE Full Text
  2. 2.↵
    1. Awada A.,
    2. van der Auwera P.,
    3. Meunier F.,
    4. Daneau D.,
    5. Klastersky J.
    Streptococcal and enterococcal bacteremia in patients with cancer. Clin. Infect. Dis. 15 1992 33 48
    OpenUrlCrossRefPubMedWeb of Science
  3. 3.↵
    1. Brantl S.,
    2. Kummer C.,
    3. Behnke D.
    Complete nucleotide sequence of plasmid pGB3631, a derivative of the Streptococcus agalactiae plasmid pIP501. Gene 142 1994 155 156
    OpenUrlCrossRefPubMed
  4. 4.↵
    1. Brisson-Noël A.,
    2. Arthur M.,
    3. Courvalin P.
    Evidence for natural gene transfer from gram-positive cocci to Escherichia coli. J. Bacteriol. 170 1988 1739 1745
    OpenUrlAbstract/FREE Full Text
  5. 5.↵
    1. Crawford I.,
    2. Russell C.
    Streptococci isolated from the bloodstream and gingival crevice of man. J. Med. Microbiol. 16 1983 263 269
    OpenUrlCrossRefPubMedWeb of Science
  6. 6.↵
    1. Douglas C. W. I.,
    2. Heath J.,
    3. Hampton K. K.,
    4. Preston F. E.
    Identity of viridans streptococci isolated from cases of infective endocarditis. J. Med. Microbiol. 39 1993 179 182
    OpenUrlCrossRefPubMedWeb of Science
  7. 7.↵
    1. Esposito S.,
    2. Noviello S.,
    3. Ianniello F.,
    4. D'Errico G.
    Erythromycin resistance in group A beta hemolytic streptococcus. Chemotherapy 44 1998 385 390
    OpenUrlCrossRefPubMed
  8. 8.↵
    1. Goldstein F. W.,
    2. Acar J. F.,
    3. The Alexander Project Collaborative Group
    Antimicrobial resistance among lower respiratory tract isolates of Streptococcus pneumoniae: results of a 1992–93 western Europe and USA collaborative surveillance study. The Alexander Project Collaborative Group. J. Antimicrob. Chemother. 38 1996 71 84
    OpenUrlCrossRefPubMed
  9. 9.↵
    1. Hamilton-Miller J. M. T.
    In-vitro activities of 14-, 15- and 16-membered macrolides against gram-positive cocci. J. Antimicrob. Chemother. 29 1992 141 147
    OpenUrlCrossRefPubMedWeb of Science
  10. 10.↵
    1. Knox K. W.,
    2. Hunter N.
    The role of oral bacteria in the pathogenesis of infective endocarditis. Aust. Dent. J. 36 1991 286 292
    OpenUrlCrossRefPubMedWeb of Science
  11. 11.↵
    1. Krah E. R. III,
    2. Macrina F. L.
    Genetic analysis of the conjugal transfer determinants encoded by the streptococcal broad-host-range plasmid pIP501. J. Bacteriol. 171 1989 6005 6012
    OpenUrlAbstract/FREE Full Text
  12. 12.↵
    1. Moreillon P.,
    2. Overholser C. D.,
    3. Malinverni R.,
    4. Bille J.,
    5. Glauser M. P.
    Predictors of endocarditis in isolates from cultures of blood following dental extractions in rats with periodontal disease. J. Infect. Dis. 157 1988 990 995
    OpenUrlCrossRefPubMed
  13. 13.↵
    1. Ono T.,
    2. Hirota K.,
    3. Nemoto K.,
    4. Fernandez E. J.,
    5. Ota F.,
    6. Fukui K.
    Detection of Streptococcus mutans by PCR amplification of spaP gene. J. Med. Microbiol. 41 1994 231 235
    OpenUrlCrossRefPubMedWeb of Science
  14. 14.↵
    1. Perkins J. B.,
    2. Youngman P. J.
    A physical and functional analysis of Tn917, a Streptococcus transposon in the Tn3 family that functions in Bacillus. Plasmid 12 1984 119 138
    OpenUrlCrossRefPubMedWeb of Science
  15. 15.↵
    1. Projan S. J.,
    2. Monod M.,
    3. Narayanan C. S.,
    4. Dubnau D.
    Replication properties of pIM13, a naturally occurring plasmid found in Bacillus subtilis, and of its close relative pE5, a plasmid native to Staphylococcus aureus. J. Bacteriol. 169 1987 5131 5139
    OpenUrlAbstract/FREE Full Text
  16. 16.↵
    1. Shaw J. H.,
    2. Clewell D. B.
    Complete nucleotide sequence of macrolide-lincosamide-streptogramin B-resistance transposon Tn917 in Streptococcus faecalis. J. Bacteriol. 164 1985 782 796
    OpenUrlAbstract/FREE Full Text
  17. 17.↵
    1. Sutcliffe J.,
    2. Grebe T.,
    3. Tait-Kamradt A.,
    4. Wondrack L.
    Detection of erythromycin-resistant determinants by PCR. Antimicrob. Agents Chemother. 40 1996 2562 2566
    OpenUrlAbstract/FREE Full Text
  18. 18.↵
    1. Tait-Kamradt A.,
    2. Clancy J.,
    3. Cronan M.,
    4. Dib-Hajj F.,
    5. Wondrack L.,
    6. Yuan W.,
    7. Sutcliffe J.
    mefE is necessary for the erythromycin-resistant M phenotype in Streptococcus pneumoniae. Antimicrob. Agents Chemother. 41 1997 2251 2255
    OpenUrlAbstract/FREE Full Text
  19. 19.↵
    1. Teng L. J.,
    2. Hsueh P. R.,
    3. Chen Y. C.,
    4. Ho S. W.,
    5. Luh K. T.
    Antimicrobial susceptibility of viridans group streptococci in Taiwan with an emphasis on the high rates of resistance to penicillin and macrolides in Streptococcus oralis. J. Antimicrob. Chemother. 41 1998 621 627
    OpenUrlCrossRefPubMedWeb of Science
View Abstract
PreviousNext
Back to top
Download PDF
Citation Tools
Susceptibilities of Oral and Nasal Isolates ofStreptococcus mitis and Streptococcus oralis to Macrolides and PCR Detection of Resistance Genes
Tsuneko Ono, Sumiko Shiota, Katsuhiko Hirota, Ken Nemoto, Tomofusa Tsuchiya, Yoichiro Miyake
Antimicrobial Agents and Chemotherapy Apr 2000, 44 (4) 1078-1080; DOI: 10.1128/AAC.44.4.1078-1080.2000

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
Print

Alerts
Sign In to Email Alerts with your Email Address
Email

Thank you for sharing this Antimicrobial Agents and Chemotherapy article.

NOTE: We request your email address only to inform the recipient that it was you who recommended this article, and that it is not junk mail. We do not retain these email addresses.

Enter multiple addresses on separate lines or separate them with commas.
Susceptibilities of Oral and Nasal Isolates ofStreptococcus mitis and Streptococcus oralis to Macrolides and PCR Detection of Resistance Genes
(Your Name) has forwarded a page to you from Antimicrobial Agents and Chemotherapy
(Your Name) thought you would be interested in this article in Antimicrobial Agents and Chemotherapy.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Share
Susceptibilities of Oral and Nasal Isolates ofStreptococcus mitis and Streptococcus oralis to Macrolides and PCR Detection of Resistance Genes
Tsuneko Ono, Sumiko Shiota, Katsuhiko Hirota, Ken Nemoto, Tomofusa Tsuchiya, Yoichiro Miyake
Antimicrobial Agents and Chemotherapy Apr 2000, 44 (4) 1078-1080; DOI: 10.1128/AAC.44.4.1078-1080.2000
del.icio.us logo Digg logo Reddit logo Twitter logo CiteULike logo Facebook logo Google logo Mendeley logo
  • Top
  • Article
    • ABSTRACT
    • ACKNOWLEDGMENTS
    • FOOTNOTES
    • REFERENCES
  • Figures & Data
  • Info & Metrics
  • PDF

KEYWORDS

Anti-Bacterial Agents
erythromycin
Mouth
Nasal Cavity
Streptococcus
Streptococcus oralis

Related Articles

Cited By...

About

  • About AAC
  • Editor in Chief
  • Editorial Board
  • Policies
  • For Reviewers
  • For the Media
  • For Librarians
  • For Advertisers
  • Alerts
  • AAC Podcast
  • RSS
  • FAQ
  • Permissions
  • Journal Announcements

Authors

  • ASM Author Center
  • Submit a Manuscript
  • Article Types
  • Ethics
  • Contact Us

Follow #AACJournal

@ASMicrobiology

       

ASM Journals

ASM journals are the most prominent publications in the field, delivering up-to-date and authoritative coverage of both basic and clinical microbiology.

About ASM | Contact Us | Press Room

 

ASM is a member of

Scientific Society Publisher Alliance

 

American Society for Microbiology
1752 N St. NW
Washington, DC 20036
Phone: (202) 737-3600

Copyright © 2021 American Society for Microbiology | Privacy Policy | Website feedback

Print ISSN: 0066-4804; Online ISSN: 1098-6596